S050 Updates in Cutaneous Oncology
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
Dermatologists’ knowledge is essential to the improvement of diagnosis and management of pediatric and adult patients with skin cancers. A multi-disciplinary panel with expertise in pediatric and adult oncodermatology, cutaneous lymphomas, Mohs surgery, and surgical oncology will provide a high-yield review of pathophysiology, state-of-the-art diagnostic studies, and discuss therapeutic strategies in cutaneous oncology patients. This session is targeted to dermatologists, residents, and practitioners involved in the care of cutaneous oncology patients
LEARNING OBJECTIVES
Outline updates in pathogenesis of non-melanoma skin cancers, Merkel cell carcinoma, melanoma, and cutaneous T-cell lymphomas in adult and pediatric patients
Discuss the latest molecular, histopathological, and imaging studies that aid in the diagnosis of cutaneous oncology patients
Identify novel therapeutic approaches and formulate management strategies for adult and pediatric patients with non-melanoma skin cancers, Merkel cell carcinoma, melanoma and cutaneous T-cell lymphomas
SCHEDULE
5:00 PM
Welcome and Introductions
Lucia Seminario-Vidal, MD, PhD, FAAD
5:05 PM
Cutaneous Squamous Cell Carcinoma Updates
Jayne S. Joo, MD, FAAD
5:35 PM
Basal Cell Carcinoma: Review and Updates
John DeNigris, MD
5:55 PM
Updates in CTCL
Ellen J. Kim, MD, FAAD
6:20 PM
Panel: Questions And Discussion
Jayne S. Joo, MD, FAAD, Ellen J. Kim, MD, FAAD
6:30 PM
Skin cancers in kids
Lauren M Metterle, MD, FAAD
6:55 PM
Upsate on the Latest Advances in Treatment of Melanoma
Vernon Sondak, MD
7:20 PM
Updates in Merkel Cell Carcinoma
Kenneth Y. Tsai, MD, PhD, FAAD
7:45 PM
Panel: Questions And Discussion
Lauren M Metterle, MD, FAAD, Vernon Sondak, MD, Kenneth Y. Tsai, MD, PhD, FAAD
SPEAKERS
John DeNigris, MD
Jayne S. Joo, MD, FAAD
Ellen J. Kim, MD, FAAD
Lauren M Metterle, MD, FAAD
Lucia Seminario-Vidal, MD, PhD, FAAD
Vernon Sondak, MD
Kenneth Y. Tsai, MD, PhD, FAAD
HANDOUTS
SPEAKER DISCLOSURES
John DeNigris, MD
No financial relationships exist with ineligible companies.
Jayne S. Joo, MD, FAAD
No financial relationships exist with ineligible companies.
Ellen J. Kim, MD, FAAD
Galderma USA – Consultant(Honoraria), Investigator(Grants/Research Funding); Innate Pharma S.A. – Investigator(Grants/Research Funding); Solgenix LLC – Investigator(Grants/Research Funding);
Lauren M Metterle, MD, FAAD
No financial relationships exist with ineligible companies.
Lucia Seminario-Vidal, MD, PhD, FAAD
Eli Lilly and Company – Employee(Salary), Employee(Stock);
Vernon Sondak, MD
Bristol-Myers Squibb – Consultant(Honoraria), Data Safety Monitoring Board(Honoraria); Genesis Drug Discovery & Development – Consultant(Honoraria); Merck – Advisory Board(Honoraria); Mural Oncology – Consultant (1099 relationship)(Honoraria); Neogene Therapeutics – Other(Grants/Research Funding); Novartis – Advisory Board(Honoraria); Regeneron – Advisory Board(Honoraria); SkylineDx B.V. – Investigator(Grants/Research Funding); Turnstone Biologics – Investigator(Grants/Research Funding);
Kenneth Y. Tsai, MD, PhD, FAAD
3CC - Third Culture Capital – Stockholder(No Compensation Received); Altos Labs – Consultant (1099 relationship)(Fees); APIS Assay Technologies – Independent Contractor(Grants/Research Funding); DX Biosciences, Inc – Consultant(Stock Options); Incyte Corporation – Investigator(Grants/Research Funding); NFlection Therapeutics, Inc – Consultant(Fees); UpToDate – Independent Contractor(Fees); Verrica Pharmaceuticals Inc – Independent Contractor(Fees);